Navigation Links
San Francisco Bay Area Affiliate of the Susan G. Komen for the Cure Funds Over $1.6 Million This Year to Community Outreach Programs
Date:7/24/2009

he Bay Area through our annual grants program to local tax exempt organizations providing breast cancer education, screening, support and treatment services to underserved women and their families. A minimum of 25 percent of our annual income is directed to the national Susan G. Komen for the Cure Grants Program for energizing science to find the cures.

About Susan G. Komen for the Cure

Susan G. Komen for the Cure was established in 1982 by Nancy Brinker to honor the memory of her sister, Susan G. Komen, who died from breast cancer at the age of 36. Today, the Organization is an international organization with a network of more than 75,000 volunteers working through local Affiliates and events like the Komen Race for the Cure(R) to eradicate breast cancer as a life-threatening disease. A global leader in the fight against breast cancer, the Organization fulfills its mission through support of innovative breast cancer research grants, meritorious awards and educational, scientific and community outreach programs around the world. Through fiscal year 2005, the Komen Organization, together with its Affiliate Network, corporate partners and generous donors, has invested $630 million in breast cancer research, education, screening and treatment programs.

About the San Francisco Bay Area Affiliate of Susan G. Komen for the Cure

The San Francisco Bay Area Affiliate of Susan G. Komen for the Cure--along with those who generously support us with their talent, time and resources--is working to better the lives of those facing breast cancer in our community. We join more than 100,000 breast cancer survivors and activists around the globe as part of the world's largest and most progressive grassroots network fighting breast cancer.

The San Francisco Bay Area Affiliate is proud to have invested over $11.0 million in local breast health and breast
'/>"/>

SOURCE Susan G. Komen for the Cure, San Francisco Affiliate
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HCV and HBV spreading more slowly among injection drug users in San Francisco
2. San Francisco Psoriasis Event Tonight Will Celebrate First National Short Sleeve Day
3. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
4. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
5. The era of global aging: GSA showcases cutting-edge San Francisco meeting topics
6. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
7. Press briefings to address longevity, mobility, brain fitness at GSAs San Francisco meeting
8. Hooray for the Bay! San Francisco Officially Named Best Place to Leave Your Heart...and Keep Your Health
9. Run-in-a-Million Run from San Francisco to Los Angeles to Raise Awareness About AIDS and HIV Testing
10. BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards
11. Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...Newswire-USNewswire/ -- Tonight, in a partisan vot...d,s version of the government takeover of health c...d in this bill; like the public option, employer a...for elective abortion, which is the most onerous a...ovides subsidies for private plans that cover elec...
(Date:11/21/2009)... for an unprecedented expansion of federally-funde... for preserving and protecting human life? If the ...ine Yoest ,, WASHINGTON, Nov. 21 /PRNewswire-...esident and CEO Dr. Charmaine Yoest responded to t...wing statement: ,, "This was a pro-abortion vo...
(Date:11/21/2009)...RNewswire-USNewswire/ -- A regional initiative lau...ver blindness) in the Americas has substantially r...rs, as evidenced by a 31% decrease in the number o...n six endemic countries. Results were reported to...iety of Tropical Medicine and Hygiene (ASTMH). ,...
(Date:11/21/2009)...2009 Test Test Test Test... Test Test Test Test Test,Test Test Test Test Test...,Test Test Test Test Test Test Test Test Test Test...t More test More test More test More test,More tes...t More test More,test More test , , Please ign...
(Date:11/21/2009)...e medical apparel company launches men,s lab coats... San Clemente, Calif. (PRWEB) November 21, 2009...pparel, today announced the launch of its men,s la...ading international trade fair for the medical ind...rates its men,s collection with three varying lab ...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3
...s called for curtailing comparative advertisements...d producers//. Suitable amendments should be made ...han, in addition to other media and channels, and ... the products of a competitor are concerned. Compa...
...years the timings for the last order for drinks ha...he clock drinking. Thousands of revelers up and ...ink in pubs and bars after midnight. // No major ...nduced violence on the streets of England and Wale...
...cough/Pertussis have tripled in Idaho (central) an...selves revaccinated against infectious respiratory...y by central district health department so far in ... the 10 year average period of 23 cases/year. ...
...charge as he was suffering from Parasomnia, but th... to have her case against him in Canadian Supreme ... woman after a party when they were both in a drun...ertain things without knowing what they are during...
...ed survey indicates that the ageing population in ... eats// three meals a day and most are non-vegetar... over 60 years in Kerala eat three meals a day, ac... population. Headed by S. Irudayarajan of the ...
...esearch team comprising Scott Belcher, PhD, did a ...ain tissue// 'at surprisingly low doses.' Wo...he first to show that oestrogen’s rapid signalling... 'BPA molecules are linked into polymers used...
Other Medicine News:Health News:Three meals daily Keeps 'Kerala's elderly Healthy 2Health News:Food packaging with Bisphenol A damages the brain 2
(Date:11/19/2009)...Newswire/ -- As the seasons change, another season...on preparing yourself. ,, Listen to this report...: ,, http://inr.mediaseed.tv/oneClip_C/?feed...nk is a division of The NewsMarket. Registered jo...and photos at http://www.thenewsmarket.com . ,...
(Date:11/19/2009)... 19 Mach 7 Technologies, a globa...age management solutions, and QStar Technologies h...- neutral archive solution through their common US...national leader in providing digital image distrib...try. Under the agreement, Data Distributing will ...
(Date:11/19/2009)...19 Impliant, Inc., a developer of ...pinal fusion surgery, announced today that it has ...as the Vice President of Clinical and Regulatory A...gi-bin/prnh/20080527/NETU060LOGO ) ,, Mr. Rol...rience in the spinal and medical device field to I...
Breaking Medicine Technology:Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Stories we tell about national trauma reflect our psychological well being 52964 1Stories we tell about national trauma reflect our psychological well being 52964 2Stories we tell about national trauma reflect our psychological well being 52964 3Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2
... - INNOVIVE Pharmaceuticals,Inc. (OTCBB:IVPH) tod... INNO-406, a potent oral dual Bcr-Abl and Lyn-kina...tolerant chronic,myelogenous leukemia, will be pre...arch Annual Meeting. The meeting takes place April...in Los Angeles,California., Information related t...
...n Valopicitabine Combined,with an Investigational ...07 /PRNewswire-FirstCall/ --,Idenix Pharmaceutical... studies of the novel combination of valopicitabin...s(R)) in both treatment-naive,and treatment- exper...n of the hepatitis C virus (HCV). These data, as w...
Other Medicine Technology:Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7
Short-Sleeve Bolero
Breast Wrap II
Breast Wrap
Sub Pectoral Breast Augmentation Wrap
Medicine Products: